Danske Bank A S increased its stake in MetLife, Inc. (NYSE:MET – Free Report) by 36.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 511,659 shares of the financial services provider’s stock after purchasing an additional 137,059 shares during the period. Danske Bank A S’s holdings in MetLife were worth $48,178,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently added to or reduced their stakes in the company. Nykredit A S bought a new position in shares of MetLife during the 2nd quarter worth approximately $178,638,000. Two Sigma Securities LLC acquired a new position in MetLife during the second quarter worth $4,204,000. NewEdge Advisors LLC raised its position in MetLife by 20.1% during the second quarter. NewEdge Advisors LLC now owns 74,002 shares of the financial services provider’s stock worth $6,261,000 after acquiring an additional 12,378 shares in the last quarter. OMERS ADMINISTRATION Corp bought a new stake in MetLife during the second quarter worth $2,683,000. Finally, Bank of Nova Scotia acquired a new stake in MetLife in the 2nd quarter valued at about $14,182,000. Institutional investors own 94.99% of the company’s stock.
MetLife Trading Up 0.0%
Shares of MET stock opened at $102.67 on Monday. The company has a current ratio of 0.21, a quick ratio of 0.21 and a debt-to-equity ratio of 0.65. MetLife, Inc. has a 1-year low of $67.33 and a 1-year high of $106.72. The stock has a 50-day moving average of $98.75 and a 200-day moving average of $86.90. The stock has a market cap of $64.52 billion, a price-to-earnings ratio of 13.39, a PEG ratio of 0.97 and a beta of 0.79.
MetLife (NYSE:MET – Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The financial services provider reported $2.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.77 by $0.01. MetLife had a net margin of 6.21% and a return on equity of 25.71%. The firm had revenue of $20.52 billion for the quarter, compared to the consensus estimate of $19.86 billion. During the same quarter in the previous year, the company earned $2.34 EPS. The company’s revenue for the quarter was up 18.2% on a year-over-year basis. On average, equities research analysts forecast that MetLife, Inc. will post 9.91 earnings per share for the current year.
MetLife Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 8th. Investors of record on Tuesday, November 3rd will be paid a dividend of $0.5925 per share. This represents a $2.37 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Tuesday, November 3rd. MetLife’s dividend payout ratio is 30.90%.
MetLife announced that its Board of Directors has approved a share repurchase program on Wednesday, August 5th that authorizes the company to repurchase $3 billion in shares. This buyback authorization authorizes the financial services provider to repurchase up to 4.8% of its stock through open market purchases. Share buyback programs are generally an indication that the company’s management believes its stock is undervalued.
MetLife News Summary
These are some of the MET news items that stood out recently:
- Positive Sentiment: Analysts raised their price targets. Mizuho lifted its target to $117 from $112 and maintained an “outperform” rating; Wells Fargo raised its target to $113 from $110 and kept an “overweight” rating. The higher targets indicate continued analyst confidence and potential upside. Mizuho price target article Wells Fargo price target article
- Neutral Sentiment: MetLife earned workplace recognition. The company was named among the 2026 Fortune World’s Best Workplaces and topped U.S.-based financial services and insurance companies on the list. This may support its reputation as an employer, though the direct impact on near-term earnings is unclear. Fortune workplace ranking article
- Negative Sentiment: CEO Michel Khalaf sold 187,425 shares for about $19.3 million, reducing his position by 19.8%. Insider sales can concern investors, although Khalaf retained 759,013 shares after the transaction. CEO share sale article
Wall Street Analyst Weigh In
Several research firms have issued reports on MET. Piper Sandler upped their price objective on MetLife from $110.00 to $115.00 and gave the company an “overweight” rating in a research note on Monday, November 9th. Jefferies Financial Group boosted their price objective on shares of MetLife from $103.00 to $115.00 and gave the company a “buy” rating in a report on Monday, August 10th. Argus increased their target price on MetLife from $93.00 to $109.00 and gave the stock a “buy” rating in a report on Wednesday, September 2nd. Keefe, Bruyette & Woods lifted their price objective on shares of MetLife from $105.00 to $108.00 and gave the company an “outperform” rating in a research note on Tuesday, August 11th. Finally, Weiss Ratings upgraded MetLife from a “buy (b)” rating to a “buy (b+)” rating in a research report on Monday, November 9th. Fourteen equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, MetLife presently has an average rating of “Moderate Buy” and a consensus price target of $107.12.
Insider Buying and Selling at MetLife
In related news, CEO Michel Khalaf sold 187,425 shares of the stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $102.97, for a total value of $19,299,152.25. Following the transaction, the chief executive officer directly owned 759,013 shares in the company, valued at $78,155,568.61. This trade represents a 19.80% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.40% of the stock is owned by insiders.
About MetLife
MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.
Read More
- Five stocks we like better than MetLife
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
